Figs (FIGS) Reports Break-Even Earnings for Q1
ZACKS· 2025-05-08 22:35
Figs (FIGS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 100%. A quarter ago, it was expected that this health care apparel company would post earnings of $0.01 per share when it actually produced earnings of $0.01, delivering no surprise.Over the last four quarters, the company has sur ...
McKesson (MCK) Tops Q4 Earnings Estimates
ZACKS· 2025-05-08 22:35
Company Performance - McKesson reported quarterly earnings of $10.12 per share, exceeding the Zacks Consensus Estimate of $9.81 per share, and up from $6.18 per share a year ago, representing an earnings surprise of 3.16% [1] - The company posted revenues of $90.82 billion for the quarter ended March 2025, which missed the Zacks Consensus Estimate by 3.08%, compared to $76.36 billion in the same quarter last year [2] - Over the last four quarters, McKesson has surpassed consensus EPS estimates three times and topped consensus revenue estimates only once [2] Stock Performance - McKesson shares have increased approximately 26.8% since the beginning of the year, while the S&P 500 has declined by 4.3% [3] - The current Zacks Rank for McKesson is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $8.33 on revenues of $93.61 billion, and for the current fiscal year, it is $36.58 on revenues of $399.57 billion [7] - The outlook for the Medical - Dental Supplies industry, where McKesson operates, is currently in the top 34% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]
Allbirds, Inc. (BIRD) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-05-08 22:35
Allbirds, Inc. (BIRD) came out with a quarterly loss of $2.73 per share versus the Zacks Consensus Estimate of a loss of $3.85. This compares to loss of $3.60 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 29.09%. A quarter ago, it was expected that this company would post a loss of $3.52 per share when it actually produced a loss of $3.23, delivering a surprise of 8.24%.Over the last four quarters, the company has surpassed ...
Sensata (ST) Q1 Earnings and Revenues Beat Estimates
ZACKS· 2025-05-08 22:31
Sensata (ST) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.89 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.33%. A quarter ago, it was expected that this maker of sensing, electrical protection, control and power management products would post earnings of $0.76 per share when it actually produced earnings of $0.76, delivering no ...
Xponential Fitness (XPOF) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-05-08 22:31
Xponential Fitness (XPOF) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of $0.15. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -233.33%. A quarter ago, it was expected that this franchisor of boutique fitness brands would post earnings of $0.44 per share when it actually produced a loss of $0.18, delivering a surprise of -140.91%.Over the last four q ...
ZipRecruiter, Inc. (ZIP) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-05-08 22:31
ZipRecruiter, Inc. (ZIP) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 23.53%. A quarter ago, it was expected that this company would post a loss of $0.11 per share when it actually produced a loss of $0.11, delivering no surprise.Over the last four quarters, the company has surpassed conse ...
JFrog Ltd. (FROG) Q1 Earnings and Revenues Surpass Estimates
ZACKS· 2025-05-08 22:31
JFrog Ltd. (FROG) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this company would post earnings of $0.14 per share when it actually produced earnings of $0.19, delivering a surprise of 35.71%.Over the last four quarters, the company has surp ...
Akamai Technologies (AKAM) Reports Q1 Earnings: What Key Metrics Have to Say
ZACKS· 2025-05-08 22:31
For the quarter ended March 2025, Akamai Technologies (AKAM) reported revenue of $1.02 billion, up 2.9% over the same period last year. EPS came in at $1.70, compared to $1.64 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.01 billion, representing a surprise of +0.64%. The company delivered an EPS surprise of +7.59%, with the consensus EPS estimate being $1.58.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall St ...
DoubleVerify Holdings (DV) Q1 Earnings Miss Estimates
ZACKS· 2025-05-08 22:31
DoubleVerify Holdings (DV) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -50%. A quarter ago, it was expected that this software platform for digital media measurement and analytics would post earnings of $0.18 per share when it actually produced earnings of $0.13, delivering a surp ...
Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates
ZACKS· 2025-05-08 22:31
Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -44%. A quarter ago, it was expected that this biotechnology company would post a loss of $0.27 per share when it actually produced a loss of $0.26, delivering a surprise of 3.70%.Over the last four quarters, the c ...